Insulin resistance correlates with disease severity in CTEPH, and an indicator may help predict clinical worsening in ...
Columnist Anna Jeter shares memories from high school and the lessons she's learned about advocating for accessibility and ...
Tenax Therapeutics said it extended Phase 3 clinical development of PH treatment TNX-103, an oral form of levosimendan.
Inhibiting the AURKB enzyme significantly improves multiple measures of blood flow in rats with pulmonary arterial ...
Celastrol, a herbal compound in traditional Chinese medicine, may help prevent BPD-PH by reducing inflammation and protecting ...
Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...
Cuts to federal budgets have the rare disease community on edge. Columnist Jen Cueva calls on us to unite for our future.
Three months of CS1 therapy boosted quality of life, while symptoms tied to heart failure and clinical worsening and ...
When it comes to sharing advice, many people with rare diseases excel at practicing what they preach, says columnist.
Males with pulmonary arterial hypertension (PAH) have more proinflammatory macrophages — a type of immune cell — in the lungs than do females with the disease, a study suggests. Researchers identified ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback